Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Oak HC/FT
AddedFeb 13, 2024
UpdatedJul 2, 2026
Oak HC/FT

Oak HC/FT

Operating

Oak HC/FT: A leading healthcare and fintech venture firm, driving industry transformation and delivering high returns.

Location
Greenwich, CT, US
Founded
2014
Firm
Analysis
Compare
Portfolio
Employees
Website

Investments

Spade
Spade
Series B

Total Raised

$56.1M

Rounds

4

Series B$40MMarch 2026
Arch
Arch
Series B

Total Raised

$77.5M

Rounds

4

Series B$52MSeptember 2025
Black Ore Technologies
Black Ore Technologies

Total Raised

$60M

Rounds

1

Seed$60MNovember 2023
Main Street Health
Main Street Health

Total Raised

$342M

Rounds

2

Series Unknown$315MOctober 2023
Clara Analytics
Clara Analytics

Total Raised

$60.5M

Rounds

4

Series C$24MSeptember 2023
August Bioservices
August Bioservices

Total Raised

$88.6M

Rounds

3

Series B$65MDecember 2022
DispatchHealth
DispatchHealth

Total Raised

$733.2M

Rounds

7

Series E$330MNovember 2022
Maven Clinic
Maven Clinic

Total Raised

$292.1M

Rounds

7

Series E$90MNovember 2022
Ethic
Ethic

Total Raised

$98.8M

Rounds

9

Series C$50MSeptember 2022
Aptos
Aptos

Total Raised

$350M

Rounds

3

Series A$150MJuly 2022
Everside Health
Everside Health

Total Raised

$329M

Rounds

2

Series Unknown$164MJuly 2022
CareBridge
CareBridge

Total Raised

$182.4M

Rounds

4

Series C$140MJune 2022
Brightline
Brightline

Total Raised

$212M

Rounds

6

Series C$105MMarch 2022
Mendel.ai
Mendel.ai

Total Raised

$65.4M

Rounds

9

Series B$40MMarch 2022
Osso VR
Osso VR

Total Raised

$109.2M

Rounds

7

Series C$66MMarch 2022
Rialtic
Rialtic

Total Raised

$79.7M

Rounds

3

Series A$28MMarch 2022
99minutos
99minutos

Total Raised

$128.6M

Rounds

6

Series C$82MMarch 2022
Reveleer
Reveleer

Total Raised

$143.8M

Rounds

10

Series Unknown$65MDecember 2021
Quartet Health
Quartet Health

Total Raised

$265.9M

Rounds

7

Corporate Round$60MDecember 2021
ZenBusiness
ZenBusiness

Total Raised

$277M

Rounds

8

Series C$200MNovember 2021
Notable Health
Notable Health

Total Raised

$119.2M

Rounds

4

Series B$100MNovember 2021
Infusion for Health
Infusion for Health

Total Raised

$50M

Rounds

1

Series Unknown$50MNovember 2021
Modern Age
Modern Age

Total Raised

$33M

Rounds

2

Series A$27MOctober 2021
Highnote
Highnote

Total Raised

$104M

Rounds

4

Series A$42.5MSeptember 2021
Axial Healthcare
Axial Healthcare

Total Raised

$116.3M

Rounds

6

Series D$75MSeptember 2021